KR
34
-3
EXR
57
-2
IPG
49
10
L
62
2
AA
51
3
TGT
25
-24
SIG
43
3
AXP
66
2
AVGO
20
-5
A
36
2
BBY
40
3
FRT
39
-2
JNPR
46
3
MRO
55
3
TEL
60
2
DAL
80
-4
K
53
2
CMCSA
48
2
AMAT
36
5
ALLE
37
5
KR
34
-3
EXR
57
-2
IPG
49
10
L
62
2
AA
51
3
TGT
25
-24
SIG
43
3
AXP
66
2
AVGO
20
-5
A
36
2
BBY
40
3
FRT
39
-2
JNPR
46
3
MRO
55
3
TEL
60
2
DAL
80
-4
K
53
2
CMCSA
48
2
AMAT
36
5
ALLE
37
5
Financhill
Back

Cartesian Therapeutics Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
26

RNAC
Cartesian Therapeutics

Last Price:
16.80
Seasonality Move:
13.13%
Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
746.67
Seasonality Move:
14.6%
Sell
26
Cartesian Therapeutics (RNAC) is a Sell

Is Cartesian Therapeutics a Buy, Sell or Hold?

  • The current Cartesian Therapeutics [RNAC] share price is $16.94. The Score for RNAC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • RNAC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $743.35. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RNAC Stock Price Chart

What is Cartesian Therapeutics's stock price today?

  • The Cartesian Therapeutics share price today is $16.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $743.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

RNAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.75 Sell
Relative Strength Index (14 RSI): 39.42 Sell
Chaikin Money Flow: -99129 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.09 - 22.05) Sell
Bollinger Bands (100): (14.31 - 20.45) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -62 Sell
Relative Strength Index (14 RSI): 13.08 Sell
Chaikin Money Flow: 151 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (783.29 - 941.63) Sell
Bollinger Bands (100): (917.99 - 1161.21) Sell

RNAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.66 Sell
20-day SMA: 19.51 Sell
50-day SMA: 19.31 Sell
200-day SMA: 20 Sell
8-day EMA: 17.92 Sell
20-day EMA: 18.95 Sell
50-day EMA: 19.03 Sell
200-day EMA: 21.01 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 780.04 Sell
20-day SMA: 834.53 Sell
50-day SMA: 964.64 Sell
200-day SMA: 1003.34 Sell
8-day EMA: 775.42 Sell
20-day EMA: 832.12 Sell
50-day EMA: 927.66 Sell
200-day EMA: 978.17 Sell

Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.

Cartesian Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):